Position in ZTS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$297,644
+$30,963 QoQ
Shares Held
4,142
+83.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#916
of 1,408 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $4,121,079 across 10 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
9,265 | $1,561,523 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,227 | $1,206,655 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,667 | $490,304 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
73,996 | $311,523 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
4,142 | $297,644 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
10,059 | $100,590 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
11,152 | $88,323 | |
| 8 | ORGO |
Organogenesis Holdings Inc.
|
15,150 | $36,814 |
All Filings in ZTS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297,644 | 4,142 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $266,681 | 2,256 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $300,080 | 2,385 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,280,397 | 15,585 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,947,503 | 12,488 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,414,508 | 8,591 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,531,216 | 9,398 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,550,144 | 7,934 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,297,252 | 7,483 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,288,534 | 7,615 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,524,683 | 7,725 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,398,277 | 8,037 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $523,518 | 3,040 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $423,589 | 2,545 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $333,254 | 2,274 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $347,295 | 2,342 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $409,098 | 2,380 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $510,513 | 2,707 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $987,589 | 4,047 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $823,347 | 4,241 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $644,246 | 3,457 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $378,896 | 2,406 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||